The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non--Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 156
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2022 AND VI 36 AND IP 3
Results: 9
1
2
EXPERT COMMENTARY ON THE PRODUCT PROFILE OF Amivantamab-vmjw.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 186
- Publication type:
- Article
3
Treatment Options in Metastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 184
- By:
- Publication type:
- Article
4
Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIs.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 178
- By:
- Publication type:
- Article
5
The Effect of Prior Cancer on Survival of Patients With Thymoma.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 172
- By:
- Publication type:
- Article
6
Single-Agent PARP Inhibitors and Combination Therapies for Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 188
- By:
- Publication type:
- Article
7
Matulonis Provides Overview of Gynecologic Treatment Landscape Advances.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 154
- By:
- Publication type:
- Article
8
Considerations for Treating Thoracic Malignancies.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 146
- Publication type:
- Article
9
The Emerging Value of ctDNA in Colon Cancer Adjuvant Therapy Decisions.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 3, p. 143
- By:
- Publication type:
- Article